CGC AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
The stock, with its moderate value rating, suggests that existing positions can be retained. For initiating new positions, it's advisable to wait for a value score above 4 and a dividend score of 2 or higher.
CGC Current Performance
1.96%
Canopy growth corp
1.19%
Avg of Sector
1.11%
S&P500
Top 10 High Relevance to CGC
| Symbol | Company Name | Value | Trend | Swing Trading | Whale Interest | Dividend | Add to Watchlist |
|---|---|---|---|---|---|---|---|
ACB | Aurora cannabis inc | 3 | 5 | 3 | - | 1 | |
XTLB | Xtl biopharmaceuticals limited | - | 4 | 3 | - | 1 | |
CRON | Cronos group inc | 4 | 3 | 2 | - | 1 | |
TLRY | Tilray brands inc | 3 | 3 | 2 | 1 | 1 | |
SNDL | Sndl inc | 4 | 5 | 2 | 1 | 1 |
- ACB Aurora cannabis incValue 3Trend 5Swing Trading 3Whale Interest -Dividend 1See more
CGC Profile
Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.